Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Change in Accured Expenses for 3 consecutive years, with $123.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 9.56% year-over-year to $123.0 million, compared with a TTM value of $94.0 million through Dec 2025, up 141.03%, and an annual FY2025 reading of $94.0 million, up 141.03% over the prior year.
  • Change in Accured Expenses was $123.0 million for Q4 2025 at GE HealthCare Technologies, down from $178.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $178.0 million in Q3 2025 and bottomed at -$232.0 million in Q2 2024.
  • Average Change in Accured Expenses over 3 years is $40.0 million, with a median of $119.5 million recorded in 2023.
  • Peak annual rise in Change in Accured Expenses hit 96.98% in 2025, while the deepest fall reached 488.24% in 2025.
  • Year by year, Change in Accured Expenses stood at $116.0 million in 2023, then rose by 17.24% to $136.0 million in 2024, then decreased by 9.56% to $123.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for GEHC at $123.0 million in Q4 2025, $178.0 million in Q3 2025, and -$7.0 million in Q2 2025.